SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bluejeans who wrote (74)8/31/1998 9:42:00 AM
From: poodle  Read Replies (1) of 1073
 
Bob, nothing new:

1. Biotech sector is loosing money.
2. Nonprofessional and/or dishonest comments from some exec., analysts, scientists, journalists misleaded the public long enough to make biotech "red light zone".
3. I am not aware of reliable working structure or system for biotech evaluation (doesn't mean it doesn't exist).
4. Patent situation is unpredictable.
5. As in any hitech area many exec. got a lot of options and hold stocks worth many times their income. It is logical for them to exit and divrsify, but with extremely low daily volume it will look like a disaster, not to mention psych. effect.

There are also general economical and polotical factors, not specifically related to biotech.

Any opinion would be appreciated.

Have a nice day
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News